RVL Pharmaceuticals plc Research and Development Expense
RVL Pharmaceuticals plc reported Research and Development Expense of $547.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2023-08-14
- RVL Pharmaceuticals plc research and development expense for the quarter ending 2023-06-30 was $547.00K, a 53.49% decline year-over-year.
- RVL Pharmaceuticals plc research and development expense for the quarter ending 2023-03-31 was $626.00K, a 27.38% decline year-over-year.
- RVL Pharmaceuticals plc research and development expense for the quarter ending 2022-12-31 was $884.00K, a 22.52% decline year-over-year.
- RVL Pharmaceuticals plc research and development expense for the quarter ending 2022-09-30 was $1.04M, a 24.13% decline year-over-year.
- RVL Pharmaceuticals plc research and development expense for fiscal 2022 was $3.97M, a 42.77% decline from fiscal 2021.
- RVL Pharmaceuticals plc research and development expense for fiscal 2021 was $6.93M, a 48.23% decline from fiscal 2020.
- RVL Pharmaceuticals plc research and development expense for fiscal 2020 was $13.39M.
- RVL Pharmaceuticals plc research and development expense for fiscal 2018 was $43.69M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | $547.00K 10-Q · filed 2023-08-14 | $1.17M 10-Q · filed 2023-08-14 | $2.06M derived: sum of 3 quarters · filed 2023-08-14 | $3.10M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2023-03-31 | $626.00K 10-Q · filed 2023-05-11 | $1.51M derived: sum of 2 quarters · filed 2023-05-11 | $2.55M derived: sum of 3 quarters · filed 2023-05-11 | $3.73M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-12-31 | $884.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $1.93M derived: sum of 2 quarters · filed 2023-03-20 | $3.10M derived: sum of 3 quarters · filed 2023-08-14 | $3.97M 10-K · filed 2023-03-20 | ||||
| 2022-09-30 | $1.04M 10-Q · filed 2022-11-10 | $2.22M derived: sum of 2 quarters · filed 2023-08-14 | $3.08M 10-Q · filed 2022-11-10 | $4.22M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-06-30 | $1.18M 10-Q · filed 2023-08-14 | $2.04M 10-Q · filed 2023-08-14 | $3.18M derived: sum of 3 quarters · filed 2023-08-14 | $4.55M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $862.00K 10-Q · filed 2023-05-11 | $2.00M derived: sum of 2 quarters · filed 2023-05-11 | $3.38M derived: sum of 3 quarters · filed 2023-05-11 | $5.43M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $2.52M derived: sum of 2 quarters · filed 2023-03-20 | $4.57M derived: sum of 3 quarters · filed 2023-03-20 | $6.93M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | $1.38M 10-Q · filed 2022-11-10 | $3.43M derived: sum of 2 quarters · filed 2022-11-10 | $5.79M 10-Q · filed 2022-11-10 | $9.76M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $2.05M 10-Q · filed 2022-08-11 | $4.26M 10-Q · filed 2022-08-11 | $8.38M derived: sum of 3 quarters · filed 2022-08-11 | $10.16M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $2.20M 10-Q · filed 2022-05-12 | $3.31M 10-Q · filed 2021-05-13 | $6.33M derived: sum of 2 quarters · filed 2022-05-12 | $8.11M derived: sum of 3 quarters · filed 2022-05-12 | $11.06M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $4.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $5.90M derived: sum of 2 quarters · filed 2022-03-30 | $8.86M derived: sum of 3 quarters · filed 2022-03-30 | $13.39M 10-K · filed 2022-03-30 | $19.70M 10-K · filed 2021-03-30 | |||
| 2020-09-30 | $1.78M 10-Q · filed 2021-11-15 | $3.73M 10-Q · filed 2020-11-10 | $4.73M derived: sum of 2 quarters · filed 2021-11-15 | $9.26M 10-Q · filed 2021-11-15 | $15.19M 10-Q · filed 2020-11-10 | $10.39M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $2.95M 10-Q · filed 2021-08-16 | $5.77M 10-Q · filed 2020-08-11 | $7.38M 10-Q · filed 2021-08-16 | $11.46M 10-Q · filed 2020-08-11 | $8.61M derived: sum of 3 quarters · filed 2021-09-08 | $16.90M derived: sum of 4 quarters · filed 2021-09-08 | ||
| 2020-03-31 | $5.69M 10-Q · filed 2021-05-13 | $5.66M derived: sum of 2 quarters · filed 2021-09-08 | $13.94M derived: sum of 3 quarters · filed 2021-09-08 | $19.30M derived: sum of 4 quarters · filed 2021-09-08 | ||||
| 2019-12-31 | -$30.00K derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | $8.26M derived: sum of 2 quarters · filed 2021-09-08 | $13.62M derived: sum of 3 quarters · filed 2021-09-08 | $23.38M 8-K · filed 2021-09-08 | $32.32M 10-K · filed 2020-03-19 | |||
| 2019-09-30 | $8.29M 10-Q · filed 2020-11-10 | $8.29M 10-Q · filed 2019-11-14 | $13.64M derived: sum of 2 quarters · filed 2020-11-10 | $23.41M 10-Q · filed 2020-11-10 | $23.41M 10-Q · filed 2019-11-14 | $38.00M derived: sum of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | $5.36M 10-Q · filed 2020-08-11 | $5.36M 10-Q · filed 2019-08-08 | $15.13M 10-Q · filed 2020-08-11 | $15.12M 10-Q · filed 2019-08-08 | $29.71M derived: sum of 3 quarters · filed 2020-08-11 | $41.68M derived: sum of 4 quarters · filed 2020-08-11 | ||
| 2019-03-31 | $9.76M 10-Q · filed 2020-05-12 | $9.76M 10-Q · filed 2019-05-09 | $24.35M derived: sum of 2 quarters · filed 2020-05-12 | $36.32M derived: sum of 3 quarters · filed 2020-05-12 | $44.29M derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | $14.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $26.55M derived: sum of 2 quarters · filed 2020-03-19 | $34.52M derived: sum of 3 quarters · filed 2020-03-19 | $43.69M 10-K · filed 2020-03-19 | $48.76M 10-K · filed 2019-03-28 | |||
| 2018-09-30 | $11.96M 10-Q · filed 2019-11-14 | $13.31M 10-Q · filed 2018-11-08 | $19.94M derived: sum of 2 quarters · filed 2019-11-14 | $29.11M 10-Q · filed 2019-11-14 | $32.45M 10-Q · filed 2018-11-08 | $51.16M derived: sum of 4 quarters · filed 2019-12-20 | ||
| 2018-06-30 | $7.97M 10-Q · filed 2019-11-14 | $8.87M 10-Q · filed 2019-08-08 | $17.14M 10-Q · filed 2019-11-14 | $18.94M 10-Q · filed 2019-08-08 | $39.19M derived: sum of 3 quarters · filed 2019-12-20 | $45.69M derived: sum of 4 quarters · filed 2019-12-20 | ||
| 2018-03-31 | $9.17M 10-Q · filed 2019-11-14 | $10.17M 10-Q · filed 2019-05-09 | $31.22M derived: sum of 2 quarters · filed 2019-12-20 | $37.71M derived: sum of 3 quarters · filed 2019-12-20 | ||||
| 2017-12-31 | $22.05M derived: 8-K 12 month − 10-Q 9 month · filed 2019-12-20 | $28.55M derived: sum of 2 quarters · filed 2019-12-20 | $40.24M 8-K · filed 2019-12-20 | $42.69M 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | $6.49M 10-Q · filed 2018-11-08 | $18.19M 10-Q · filed 2018-11-08 |